High glucose concentration produces a short-term increase in pERK1/2 and p85 proteins, having a direct angiogenetic effect by an action similar to VEGF.
Angiogenesis Inducing Agents
/ metabolism
Cell Proliferation
/ drug effects
Cells, Cultured
Class Ia Phosphatidylinositol 3-Kinase
/ metabolism
Dose-Response Relationship, Drug
Endothelial Cells
/ drug effects
Glucose
/ pharmacology
Humans
Mitogen-Activated Protein Kinase 1
/ metabolism
Mitogen-Activated Protein Kinase 3
/ metabolism
Phosphorylation
/ drug effects
Up-Regulation
/ drug effects
Vascular Endothelial Growth Factor A
/ pharmacology
Diabetes
Endothelial differentiation
Glucose
Hyperglycemia
VEGF
Journal
Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
30
12
2019
accepted:
10
02
2020
pubmed:
5
3
2020
medline:
24
9
2020
entrez:
5
3
2020
Statut:
ppublish
Résumé
Excessive glucose serum concentration, endothelial dysfunction and microangiopathy are key features of diabetes mellitus, being both diagnostic parameters and pathogenetic mechanisms. Vascular endothelial growth factor (VEGF) is importantly implicated in the physiology and pathology of blood vessels, including diabetic vascular damage. These factors certainly affect endothelial cells, and to evaluate mechanisms involved, we took advantage of telomerase-immortalized human microvascular endothelial (TIME) cells. TIME cells were exposed to different glucose concentrations and to VEGF treatments. Culture conditions also included the use of basement membrane extract, as an in vitro differentiation model. Cell morphology was then evaluated in the different conditions, and cellular proteins were extracted to analyze specific protein products by Western blot. High glucose concentrations and VEGF did substantially affect neither morphology nor growth of cultured TIME cells, while both considerably increased differentiation into "capillary-like" structures when cells were cultured on basement membrane extract. Under these conditions, high glucose concentration and VEGF also produced a short-term increase in pERK1/2 and p85 proteins, while total and phosphorylated AKT were not affected. These data suggest a direct angiogenetic effect of glucose, affecting intracellular transduction mechanisms with an action similar to that of VEGF. This effect on endothelial cell proliferation and differentiation could be part of pathogenetic mechanisms producing diabetic microvascular alterations.
Identifiants
pubmed: 32130518
doi: 10.1007/s00592-020-01501-z
pii: 10.1007/s00592-020-01501-z
doi:
Substances chimiques
Angiogenesis Inducing Agents
0
Vascular Endothelial Growth Factor A
0
Class Ia Phosphatidylinositol 3-Kinase
EC 2.7.1.137
MAPK1 protein, human
EC 2.7.11.24
Mitogen-Activated Protein Kinase 1
EC 2.7.11.24
Mitogen-Activated Protein Kinase 3
EC 2.7.11.24
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
947-958Subventions
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 200832E9J9_003
Références
Ding J, Liu Y, Sullivan DA (2015) Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci 56:7814–7820
doi: 10.1167/iovs.15-18049
Uemura S, Matsushita H, Li W et al (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88:1291–1298
doi: 10.1161/hh1201.092042
Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412
doi: 10.2337/diab.40.4.405
Curcio F, Ceriello A (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. Vitro Cell Dev Biol 28A:787–790
doi: 10.1007/BF02631069
Wang D, Wang Q, Yan G et al High glucose and interleukin 1β-induced apoptosis in human umbilical vein endothelial cells involves in down-regulation of monocarboxylate transporter 4. Biochem Biophys Res Commun 466:607–614
doi: 10.1016/j.bbrc.2015.09.016
Du X, Matsumura T, Edelstein D et al (2003) Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyper-glycemic damage in endothelial cells. J Clin Investig 112(7):1049–1057
doi: 10.1172/JCI18127
McGinn S, Poronnik P, King M, Gallery ED, Pollock CA (2003) High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity. Am J Physiol Cell Physiol 284(6):C1374–C1386
doi: 10.1152/ajpcell.00466.2002
Shao Y, Li X, Wood JW, Ma J-X (2018) Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy. J Diabetes Complic 32:966–973. https://doi.org/10.1016/j.jdiacomp.2018.06.015
doi: 10.1016/j.jdiacomp.2018.06.015
Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174–190. https://doi.org/10.1111/nyas.12412
doi: 10.1111/nyas.12412
pubmed: 24673341
pmcid: 4154702
Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450
doi: 10.1016/S0002-9394(14)75794-0
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487. https://doi.org/10.1056/NEJM199412013312203
doi: 10.1056/NEJM199412013312203
pubmed: 7526212
Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE (2000) Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157(1):135–144
doi: 10.1016/S0002-9440(10)64525-7
Wirostko B, Wong TY, Simó R (2008) Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 27:608–621. https://doi.org/10.1016/j.preteyeres.2008.09.002
doi: 10.1016/j.preteyeres.2008.09.002
pubmed: 18929676
Wang W, Lo ACY (2018) Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 19:1816. https://doi.org/10.3390/ijms19061816
doi: 10.3390/ijms19061816
pmcid: 6032159
Hueber A, Wiedemann P, Esser PHK (1996) Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int Ophthalmol 20:345–350
pubmed: 9237137
Haurigot V, Villacampa P, Ribera A et al (2009) Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem 284:22961–22969. https://doi.org/10.1074/jbc.M109.014787
doi: 10.1074/jbc.M109.014787
pubmed: 19473988
pmcid: 2755703
Wilkinson-Berka JL, Wraight C, Werther G (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13:3307–3317
doi: 10.2174/092986706778773086
Patel JI, Hykin PG, Gregor ZJ et al (2005) Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol 89:480–483. https://doi.org/10.1136/bjo.2004.049940
doi: 10.1136/bjo.2004.049940
pubmed: 15774928
pmcid: 1772595
Coxon A, Bready J, Min H et al (2010) Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody. Mol Cancer Ther 9:2641–2651. https://doi.org/10.1158/1535-7163.MCT-10-0213
doi: 10.1158/1535-7163.MCT-10-0213
pubmed: 20937592
pmcid: 4430860
Astaneie F, Afshari M, Mojtahedi A et al (2005) Total antioxidant capacity and levels of epidermal growth factor andnitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 36(4):376–381
doi: 10.1016/j.arcmed.2005.03.007
Eckardt K-U (2009) Erythropoietin and microvascular diabetic complications. Nephrol Dial Transplant 24:388–390. https://doi.org/10.1093/ndt/gfn590
doi: 10.1093/ndt/gfn590
pubmed: 18952703
Karaman S, Leppänen V-M, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145:dev151019. https://doi.org/10.1242/dev.151019
doi: 10.1242/dev.151019
pubmed: 30030240
Venetsanakos E, Mirza A, Fanton C et al (2002) Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 273:21–33. https://doi.org/10.1006/excr.2001.5424
doi: 10.1006/excr.2001.5424
pubmed: 11795943
Yang J, Chang E, Cherry AM et al (1999) Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141–26148. https://doi.org/10.1074/jbc.274.37.26141
doi: 10.1074/jbc.274.37.26141
pubmed: 10473565
Lee KM, Choi KH, Ouellette MM (2004) Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45:33–38. https://doi.org/10.1007/10.1007/s10616-004-5123-3
doi: 10.1007/10.1007/s10616-004-5123-3
pubmed: 19003241
pmcid: 3449956
Shao R, Guo X (2004) Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun 321:788–794. https://doi.org/10.1016/j.bbrc.2004.07.033
doi: 10.1016/j.bbrc.2004.07.033
pubmed: 15358096
Chang MW-F, Grillari J, Mayrhofer C et al (2005) Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp Cell Res 309:121–136. https://doi.org/10.1016/j.yexcr.2005.05.002
doi: 10.1016/j.yexcr.2005.05.002
pubmed: 15964568
Kashyap MV, Ranjan AP, Shankardas J, Vishwanatha JK (2013) Establishment of human retinal microvascular endothelial cells with extended life-span. In Vivo 27:685–694
pubmed: 24292569
Olofsson B, Porsch H, Heldin P (2014) Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine production. PLoS ONE 9:e90921. https://doi.org/10.1371/journal.pone.0090921
doi: 10.1371/journal.pone.0090921
pubmed: 24614402
pmcid: 3948721
Chung C-H, Wu W-B, Huang T-F (2004) Aggretin, a snake venom-derived endothelial integrin 2 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 103:2105–2113. https://doi.org/10.1182/blood-2003-07-2483
doi: 10.1182/blood-2003-07-2483
pubmed: 14630793
Chin H, Horng C, Liu Y et al (2018) Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Oncol Rep 39:2351–2357. https://doi.org/10.3892/or.2018.6312
doi: 10.3892/or.2018.6312
pubmed: 29565448
Caputo M, De Rosa MC, Rescigno T et al (2014) Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element. Cell Biochem Funct 32:637–646. https://doi.org/10.1002/cbf.3067
doi: 10.1002/cbf.3067
pubmed: 25264165
Mortuza R, Chen S, Feng B et al (2013) High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE 8:e54514. https://doi.org/10.1371/journal.pone.0054514
doi: 10.1371/journal.pone.0054514
pubmed: 23342163
pmcid: 3546959
Felice F, Lucchesi D, di Stefano R et al (2010) Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells: evidence for differential glutathione peroxidase-1 expression. Microvasc Res 80(3):332–338. https://doi.org/10.1016/j.mvr.2010.05.004
doi: 10.1016/j.mvr.2010.05.004
pubmed: 20471990
Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185–194. https://doi.org/10.1083/jcb.147.1.185
doi: 10.1083/jcb.147.1.185
pubmed: 10508865
pmcid: 2164984
Piehl C, Piontek J, Cording J et al (2010) Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules. Cell Mol Life Sci 67:2131–2140. https://doi.org/10.1007/s00018-010-0332-8
doi: 10.1007/s00018-010-0332-8
pubmed: 20333434
Shah AV, Birdsey GM, Randi AM (2016) Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG. Vascul Pharmacol 86:3–13. https://doi.org/10.1016/j.vph.2016.05.003
doi: 10.1016/j.vph.2016.05.003
pubmed: 27208692
pmcid: 5404112
Birdsey GM, Shah AV, Dufton N et al (2015) The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling. Dev Cell 32:82–96. https://doi.org/10.1016/j.devcel.2014.11.016
doi: 10.1016/j.devcel.2014.11.016
pubmed: 25584796
pmcid: 4292982
Sperone A, Dryden NH, Birdsey GM et al (2011) The transcription factor erg inhibits vascular inflammation by repressing NF-κB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 31:142–150. https://doi.org/10.1161/ATVBAHA.110.216473
doi: 10.1161/ATVBAHA.110.216473
pubmed: 20966395
Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117:3–32
doi: 10.1007/978-1-4419-8871-3_1
Schenone S, Manetti F, Botta M (2007) SRC inhibitors and angiogenesis. Curr Pharm Des 13:2118–2128
doi: 10.2174/138161207781039580
Siemann DW, Horsman MR (2009) Vascular targeted therapies in oncology. Cell Tissue Res 335:241–248. https://doi.org/10.1007/s00441-008-0646-0
doi: 10.1007/s00441-008-0646-0
pubmed: 18752004
Nussenbaum F, Herman IM (2010) Tumor angiogenesis: insights and innovations. J Oncol 2010:132641. https://doi.org/10.1155/2010/132641
doi: 10.1155/2010/132641
pubmed: 20445741
pmcid: 2860112
Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154–165. https://doi.org/10.1016/j.ceb.2008.12.012
doi: 10.1016/j.ceb.2008.12.012
pubmed: 19230644
Ahluwalia A, Jones MK, Brzozowska I, Tarnawski AS (2017) In vitro model of vasculo-angiogenesis: demonstration that bone marrow derived endothelial progenitor cells form new hybrid capillary blood vessels jointly with gastric endothelial cells. J Physiol Pharmacol 68(6):841–846
pubmed: 29550796
Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586:4401–4408. https://doi.org/10.1113/jphysiol.2008.156695
doi: 10.1113/jphysiol.2008.156695
pubmed: 18565995
pmcid: 2614025
Jindal V (2015) Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy. Mol Neurobiol 51:878–884. https://doi.org/10.1007/s12035-014-8732-7
doi: 10.1007/s12035-014-8732-7
pubmed: 24826918
Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52:1156–1163. https://doi.org/10.1167/iovs.10-6293
doi: 10.1167/iovs.10-6293
pubmed: 21357409
pmcid: 3053099
Di Zazzo E, Feola A, Zuchegna C et al (2014) The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility. Sci World J. https://doi.org/10.1155/2014/565839
doi: 10.1155/2014/565839
Winnay JN, Kahn CR (2011) PI 3-kinase regulatory subunits as regulators of the unfolded protein response. Methods Enzymol 490:147–158. https://doi.org/10.1016/B978-0-12-385114-7.00009-X
doi: 10.1016/B978-0-12-385114-7.00009-X
pubmed: 21266249
pmcid: 4371597